Valiant Laboratories share price
You have to be logged in to add this to Watchlist.- ₹79.00(-1.31%)November 14, 2025 15:26:17 PM IST
- NSE
- BSE
- Vol : 13.93K (NSE + BSE)Last 20 day avg : 32.31 K
Valiant Laboratories is trading -1.31% lower at Rs 79.00 as compared to its last closing price. Valiant Laboratories has been trading in the price range of 82.22 & 79.00. Valiant Laboratories has given -22.81% in this year & -1.84% in the last 5 days. Valiant Laboratories has TTM P/E ratio 3,651.79 as compared to the sector P/E of 30.99.The company posted a net profit of 1.82 Crores in its last quarter.Listed peers of Valiant Laboratories include Qualitek Labs (-0.73%), Valiant Laboratories (-1.31%), Bizotic Commercial (2.00%).The Mutual Fund holding in Valiant Laboratories was at -% in . The MF holding has - from the last quarter. The FII holding in Valiant Laboratories was at 0.02% in 30 Sep 2025. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Nov 15, 2025, 06:41 AM UTC
- Debt To EquityHigher than industry0.52The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- Beta-Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
- Income
- Balance Sheet
- Cash Flow
- Financial
- Valuation
Company is profitable- Company has registered a profit of 1.82 cr vs a loss of 0.51 cr in the same quarter last year.
The debt to equity of the company is higher than the industry median- Earnings are insufficient to cover the interest expenses on outstanding debt
- R1
- 84.87
- R2
- 89.73
- R3
- 92.67
- S1
- 77.07
- S2
- 74.13
- S3
- 69.27
- Very Bearish
- Bearish
- Neutral
- Very Bullish
- Bullish
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Qualitek Labs | Neutral | 398.95 | -0.73 | 398.14 | 65.54 | 4.53 | - | 22.34 |
| Valiant Laboratories | Bearish | 79.00 | -1.31 | 428.96 | - | 1.77 | - | 44.64 |
| Bizotic Commercial | Bullish | 783.80 | 2.00 | 630.17 | 105.84 | 7.81 | - | - |
| Vraj Iron And Steel | Bearish | 139.00 | 0.43 | 461.46 | 10.39 | 1.23 | - | 0.36 |
| Neetu Yoshi | Neutral | 120.30 | 3.62 | 467.31 | 29.49 | 10.85 | - | 13.95 |
- Promoter(s) holds a high stake in the company at 74.94%
- FIIs are invested in this company
- FIIs holding has decreased by 0.50 percentage points from previous quarter
- Mutual Funds are not invested in this company.
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-11-11 | Quarterly Results |
| 2025-08-08 | Quarterly Results |
| 2025-07-09 | Others |
| 2025-05-20 | Audited Results |
| 2025-02-07 | Quarterly Results & Others |
- Industry
- ISININE0JWS01017
- BSE Code543998
- NSE CodeVALIANTLAB
Valiant Laboratories is trading at 79.00 as on Fri Nov 14 2025 09:56:17. This is -1.31% lower as compared to its previous closing price of 80.05.
The market capitalization of Valiant Laboratories is 428.96 Cr as on Fri Nov 14 2025 09:56:17.
The 52 wk high for Valiant Laboratories is 126.97 whereas the 52 wk low is 70.41
Valiant Laboratories can be analyzed on the following key metrics -
- TTM P/E: 3651.79
- Sector P/E: 30.99
- Dividend Yield: 0.00%
- D/E ratio: -
Valiant Laboratories reported a net profit of -2.20 Cr in 2025.